Moreover, A2AR expression is upregulated in patients with AF and prevention of A2AR activation normalizes spontaneous calcium release in patients with AF to levels observed in patients without AF [13], and diminishes the induction of arrhythmic responses in electrically paced myocytes from patients with AF [14]. The gene discussed is ADORA2A; the disease is atrial fibrillation.